Launched on 12/01/2006, the Invesco S&P 100 Equal Weight ETF (EQWL) is a passively managed exchange traded fund designed to provide a broad exposure to the Large Cap Blend segment of the US equity market.
The fund is sponsored by Invesco. It has amassed assets over $969.42 million, making it one of the larger ETFs attempting to match the Large Cap Blend segment of the US equity market.
Why Large Cap Blend
Companies that fall in the large cap category tend to have a market capitalization above $10 billion. They tend to be stable companies with predictable cash flows and are usually less volatile than mid and small cap companies.
Blend ETFs are aptly named, since they tend to hold a mix of growth and value stocks, as well as show characteristics of both kinds of equities.
Costs
Investors should also pay attention to an ETF's expense ratio. Lower cost products will produce better results than those with a higher cost, assuming all other metrics remain the same.
Annual operating expenses for this ETF are 0.25%, putting it on par with most peer products in the space.
It has a 12-month trailing dividend yield of 1.84%.
Sector Exposure and Top Holdings
Even though ETFs offer diversified exposure which minimizes single stock risk, it is still important to look into a fund's holdings before investing. Luckily, most ETFs are very transparent products that disclose their holdings on a daily basis.
This ETF has heaviest allocation to the Financials sector--about 18.60% of the portfolio. Information Technology and Healthcare round out the top three.
Looking at individual holdings, Broadcom Inc (AVGO) accounts for about 1.29% of total assets, followed by Pfizer Inc (PFE) and 3m Co (MMM).
The top 10 holdings account for about 10.88% of total assets under management.
Performance and Risk
EQWL seeks to match the performance of the Russell Top 200 Equal Weight Index before fees and expenses. The S&P 100 Equal Weight Index is designed to provide equal-weighted exposure to the securities of the largest 200 companies in the US equity market.
The ETF has added about 1.22% so far this year and is up roughly 21.05% in the last one year (as of 01/17/2025). In the past 52-week period, it has traded between $86.87 and $107.72.
The ETF has a beta of 0.97 and standard deviation of 15.43% for the trailing three-year period, making it a medium risk choice in the space. With about 102 holdings, it effectively diversifies company-specific risk.
Alternatives
Invesco S&P 100 Equal Weight ETF carries a Zacks ETF Rank of 3 (Hold), which is based on expected asset class return, expense ratio, and momentum, among other factors. Thus, EQWL is a reasonable option for those seeking exposure to the Style Box - Large Cap Blend area of the market. Investors might also want to consider some other ETF options in the space.
The iShares Core S&P 500 ETF (IVV) and the SPDR S&P 500 ETF (SPY) track a similar index. While iShares Core S&P 500 ETF has $593.07 billion in assets, SPDR S&P 500 ETF has $626.79 billion. IVV has an expense ratio of 0.03% and SPY charges 0.09%.
Bottom-Line
Passively managed ETFs are becoming increasingly popular with institutional as well as retail investors due to their low cost, transparency, flexibility and tax efficiency. They are excellent vehicles for long term investors.
To learn more about this product and other ETFs, screen for products that match your investment objectives and read articles on latest developments in the ETF investing universe, please visit Zacks ETF Center.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week.
Get it free >>Invesco S&P 100 Equal Weight ETF (EQWL): ETF Research Reports
Pfizer Inc. (PFE) : Free Stock Analysis Report
3M Company (MMM) : Free Stock Analysis Report
Broadcom Inc. (AVGO) : Free Stock Analysis Report
SPDR S&P 500 ETF (SPY): ETF Research Reports
iShares Core S&P 500 ETF (IVV): ETF Research Reports
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
%20Strong%20Buy%20Recommendation%20%7C%20Nasdaq&_biz_n=0&rnd=261055&cdn_o=a&_biz_z=1743331959478)
%20Be%20on%20Your%20Investing%20Radar%3F%20%7C%20Nasdaq&_biz_n=1&rnd=932763&cdn_o=a&_biz_z=1743331959479)
%20Be%20on%20Your%20Investing%20Radar%3F%20%7C%20Nasdaq&rnd=722104&cdn_o=a&_biz_z=1743331959484)
%20Be%20on%20Your%20Investing%20Radar%3F%20%7C%20Nasdaq&_biz_n=1&rnd=932763&cdn_o=a&_biz_z=1743331962479)
%20Be%20on%20Your%20Investing%20Radar%3F%20%7C%20Nasdaq&_biz_n=1&rnd=932763&cdn_o=a&_biz_z=1743331962480)